| 1. Barnes PJ. Pulmonary pharmacology. In: Brunton LL, Chabner BA, Knollmann BC (Eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th edn. New York: McGraw-Hill, 2011. pp. 1031–57. | | | | 2. McFadden ER Jr. Asthma In: Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS (Eds.). Harrison's Principles of Internal Medicine, 16th edn. New York: McGraw-Hill, 2005. pp. 1508–16. | | | | 3. Dartnell J. Activities to improve hospital prescribing. Aust Prescr. 2001;24:29–31. | | | | 4. George J, Senthilkumar AB, Rajendran SD, Suresh B. Drug prescribing audit of ranitidine: a government hospital experience. Indian J Pharmaceut Sci. 2001;63:491–9. | | | | 5. National Heart, Lung, and Blood Institute, National Institutes of Health. International Consensus Report on the Diagnosis and Treatment of Asthma. Bethesda: National Heart, Lung, and Blood Institute, National Institutes of Health, March 1992. Publication no. 92-3091. | | | | 6. NIH. Guidelines for the Diagnosis and Management of Asthma. Bethesda: National Institutes of Health (NIH), May 1997. p. 41 Publication no. 97-4051 A. | | | | 7. National Heart, Lung and Blood Institute, WHO. Global Strategy for Asthma Management and Prevention. Bethesda: NHLBI/WHO workshop, 1997. NIH Publication no. 974051. | | | | 8. Drummond N, Abdalla M, Bcukingham JK, Osman LM. Effectiveness of routine self monitoring of peak flow in patients with asthma. BMJ. 1994;308:564–7. [DOI via Crossref] | | | | 9. Kumar A, Tiwari HK, Kulkarni SK. Drug utilization assessment in asthma therapy through prescription monitoring. IJHP. 2004; 41:70–2. | | |
|
|
